Created collaboratively by committee members, the Principles Statement is comprised of four key principles and associated actions that are vital to the work of ensuring all trials are diverse, inclusive, and equitable.
Created collaboratively by committee members, ACRO’s latest DCT
Tool Navigating Change During Rapid Transformation: A Question-
and-Answer Resource for Decentralized Clinical Trials is designed to
address risk aversion and support stakeholders in successfully
embracing change.
Our member companies have faced widespread clinical trial disruptions
in the past few years - from the global pandemic, to the war in Ukraine.
We developed a recommendation for how sponsors and CROs should
report study disruptions in a Clinical Study Report (CSR).
Read about ACRO’s initiatives, COVID-19 efforts, and more.
Take a look at how our members are innovating in top focus areas.
Decentralization in #ClinicalTrials is on the rise, and teams studying certain kinds of therapies are turning to the method more than others. See the top five types of trials using at least one #DCT practice based on 12 years of global #data: https://bit.ly/3XMuvvy
With new #tech, #ClinicalTrial organizations can reduce the costs associated with drug and device development. Here are five ways to minimize these expenses, from drug-behavior predictions through #AI to relying on remote monitoring: https://bit.ly/3gNNiWB
Researchers can turn to long-term follow-up studies to better understand the efficacy of a drug in the real world — and patient centricity can provide greater value and stability. @Labcorp explores the topic and three planning considerations: http://bit.ly/3GV0ZxC
Get ACRO’s newsletter to stay informed about our work and the industry.
WASHINGTON, DC – Today, the Association of Clinical Research Organizations (ACRO)’s DCT Working Party releases the latest addition to its DCT Toolkit:…
Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war…
WASHINGTON, DC – This week, the Association of Clinical Research Organizations (ACRO)’s Diversity and Inclusion in Clinical Trials committee is proud to…
The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…
Washington, DC — On March 16, 2022, ACRO’s Board of Directors was joined by more than 125 clinical research stakeholders – including…
Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jackie…
Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »
ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »
ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »
In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »
ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »
We help create a global regulatory and business environment
where ACRO members succeed
';